Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Katherine, Vlessis"'
Autor:
Cecelia P. Tamburro, Robert A. Hegele, Catherine Sillari, Nilanjan Chatterjee, Jack W. O’Sullivan, A. Cecile J.W. Janssens, Kelly E. Ormond, Megan C. Roberts, Robb Rowley, Samuel A. Lambert, Jacqueline S. Dron, Muin J. Khoury, Jacqueline Al MacArthur, Mark I McCarthy, Douglas F. Easton, Charles Kooperberg, Deanna Brockman, Antonis C. Antoniou, Hannah Wand, Karen Edwards, Katrina A.B. Goddard, Kim Kinnear, John Danesh, Iftikhar J. Kullo, Genevieve L. Wojcik, Erin M. Ramos, Eric Venner, Michael A. Iacocca, Peter Kraft, Michael Inouye, Amit Khera, Helen Parkinson, Katherine Vlessis
Publikováno v:
Nature, vol 591, iss 7849
Nature
Nature
Polygenic risk scores (PRSs), which often aggregate results from genome-wide association studies, can bridge the gap between initial discovery efforts and clinical applications for the estimation of disease risk using genetics. However, there is nota
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e15ab19fdf191c610ba5ab01b9978b75
Autor:
Muin J. Khoury, Jacqueline S. Dron, Robert A. Hegele, Katrina A.B. Goddard, Michael Inouye, Catherine Sillari, Peter Kraft, Kim Kinnear, Charles Kooperberg, Hannah Wand, Nilanjan Chatterjee, Erin M. Ramos, Kelly E. Ormond, Helen Parkinson, Eric Venner, Jacqueline Al MacArthur, Jack W. O’Sullivan, Karen Edwards, Michael A. Iacocca, Amit Khera, John Danesh, Megan C. Roberts, Iftikhar J. Kullo, Genevieve L. Wojcik, Mark I McCarthy, Douglas F. Easton, Antonis C. Antoniou, Robb Rowley, Samuel A. Lambert, Katherine Vlessis, A. Cecile J.W. Janssens, Deanna Brockman, Cecelia P. Tamburro
Polygenic risk scores (PRS), often aggregating the results from genome-wide association studies, can bridge the gap between the initial variant discovery efforts and disease risk estimation for clinical applications. However, there is remarkable hete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d600eac0e1ea73ceecf1eb9f36fe552
Autor:
Natasha Purington, Nicolette M. Chun, James M. Ford, Sigurdis Haraldsdottir, Katherine Vlessis
Publikováno v:
JNCI Cancer Spectrum. 4
Background The National Comprehensive Cancer Network (NCCN) recommends germline testing for pathogenic BRCA1/2 mutations identified by somatic tumor sequencing. The aim of this study was to explore whether patients at Stanford with somatic BRCA1/2 mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8be8c64577dc97213486b76bd7edb34
https://doi.org/10.1093/jncics/pkz095
https://doi.org/10.1093/jncics/pkz095
Autor:
Katherine, Vlessis, Natasha, Purington, Nicolette, Chun, Sigurdis, Haraldsdottir, James M, Ford
Publikováno v:
JNCI Cancer Spectrum
Background The National Comprehensive Cancer Network (NCCN) recommends germline testing for pathogenic BRCA1/2 mutations identified by somatic tumor sequencing. The aim of this study was to explore whether patients at Stanford with somatic BRCA1/2 mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f7f583d316ffeb37caeaf1f74b784dd8
https://pubmed.ncbi.nlm.nih.gov/32259017
https://pubmed.ncbi.nlm.nih.gov/32259017